EGFR and lung adenocarcinoma: Therefore, multicenter and prospective observational studies are needed to collect more detailed variables and samples to validate the accuracy and practicability of the neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in predicting the prognosis of patients with stage I EGFR-altered lung adenocarcinoma after surgery.